SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 90.7 TWD -1.41% Market Closed
Market Cap: 6.4B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

Gross Margin
SciVision Biotech Inc

74.8%
Current
69%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.8%
=
Gross Profit
621.7m
/
Revenue
831.4m

Gross Margin Across Competitors

Country TW
Market Cap 6.4B TWD
Gross Margin
75%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Country CH
Market Cap 38.7B CHF
Gross Margin
55%
Country DK
Market Cap 204B DKK
Gross Margin
68%
Country US
Market Cap 17.2B USD
Gross Margin
70%
Country KR
Market Cap 9.8T KRW
Gross Margin
15%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Country CA
Market Cap 7B USD
Gross Margin
61%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Country UK
Market Cap 4.9B GBP
Gross Margin
56%
Country US
Market Cap 6B USD
Gross Margin
47%
No Stocks Found

SciVision Biotech Inc
Glance View

Market Cap
6.4B TWD
Industry
Health Care

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Intrinsic Value
178.54 TWD
Undervaluation 49%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
74.8%
=
Gross Profit
621.7m
/
Revenue
831.4m
What is the Gross Margin of SciVision Biotech Inc?

Based on SciVision Biotech Inc's most recent financial statements, the company has Gross Margin of 74.8%.